METABOLISM OF METHOXYPHENAMINE IN EXTENSIVE AND POOR METABOLIZERS OF DEBRISOQUIN

被引：36
|
作者：
ROY, SD
HAWES, EM
MCKAY, G
KORCHINSKI, ED
MIDHA, KK
机构：
[1] UNIV SASKATCHEWAN, COLL PHARM, SASKATOON S7N 0W0, SASKATCHEWAN, CANADA
[2] UNIV SASKATCHEWAN, COLL MED, SASKATOON S7N 0W0, SASKATCHEWAN, CANADA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 38卷 / 02期
关键词：
D O I：
10.1038/clpt.1985.148
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：128 / 133
页数：6
相关论文
共 50 条
  • [31] Codeine and morphine in extensive and poor metabolizers of sparteine: Pharmacokinetics, analgesic effect and side effects
    Poulsen, L
    Brosen, K
    ArendtNielsen, L
    Gram, LF
    Elbaek, K
    Sindrup, SH
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 51 (3-4) : 289 - 295
  • [32] Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
    Pedersen, Rasmus Steen
    Damkier, Per
    Brosen, Kim
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 513 - 521
  • [33] Stereoselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19.
    Shin, J
    Kim, K
    Shon, J
    Park, J
    Yun, D
    Cha, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P98 - P98
  • [34] Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers
    Rasmus Steen Pedersen
    Per Damkier
    Kim Brøsen
    European Journal of Clinical Pharmacology, 2006, 62 : 513 - 521
  • [35] Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19
    Kim, KA
    Shon, JH
    Park, JY
    Yoon, YR
    Kim, MJ
    Yun, DH
    Kim, MK
    Cha, IJ
    Hyun, MH
    Shin, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (01) : 90 - 99
  • [36] Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan
    Barbhaiya, RH
    Buch, AB
    Greene, DS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (05) : 573 - 581
  • [37] Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers
    Pope, LE
    Khalil, MH
    Berg, JE
    Stiles, M
    Yakatan, GJ
    Sellers, EM
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (10): : 1132 - 1142
  • [38] POLYMORPHIC OCHRATOXIN-A HYDROXYLATION IN RAT STRAINS PHENOTYPED AS POOR AND EXTENSIVE METABOLIZERS OF DEBRISOQUINE
    CASTEGNARO, M
    BARTSCH, H
    BEREZIAT, JC
    ARVELA, P
    MICHELON, J
    BROUSSOLLE, L
    XENOBIOTICA, 1989, 19 (02) : 225 - 230
  • [39] Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese
    Yasumori, T.
    Narita, H.
    Matsuda, T.
    Takubo, T.
    Ogawa, M.
    Ishii, M.
    Hara, K.
    Ishii, Y.
    Okuyama, K.
    Fujimoto, G.
    Ochiai, H.
    Kano, A.
    Hasegawa, S.
    Sato, K.
    Taniguchi, T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (11) : 939 - 946
  • [40] Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese
    T. Yasumori
    H. Narita
    T. Matsuda
    T. Takubo
    M. Ogawa
    M. Ishii
    K. Hara
    Y. Ishii
    K. Okuyama
    G. Fujimoto
    H. Ochiai
    A. Kano
    S. Hasegawa
    K. Sato
    T. Taniguchi
    European Journal of Clinical Pharmacology, 2006, 62 : 939 - 946
12345